NASDAQ: NMRANeumora Therapeutics Inc Stock Ownership - Who owns Neumora Therapeutics?
Insider buying vs selling
Have Neumora Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Arch Venture Partners XII LLC | 10% Owner | 2025-10-27 | 1,915,700 | $2.61 | $5.00MBuy |
| Arch Venture Partners X LLC | 10% Owner | 2025-10-27 | 1,915,700 | $2.61 | $5.00MBuy |
| Kristina Burow | Director | 2025-10-27 | 1,915,700 | $2.61 | $5.00MBuy |
| Paul L. Berns | Title Chief Executive Officer and Chairman of the Board | 2025-02-18 | 13,871 | $1.69 | $23.47kSell |
| Joshua Pinto | President | 2025-02-18 | 8,048 | $1.68 | $13.48kSell |
| Robert A. Lenz | Head of RD | 2025-02-18 | 5,614 | $1.67 | $9.38kSell |
| Michael Lee Milligan | Title Chief Financial Officer Principal Accounting Officer | 2025-02-18 | 1,978 | $1.69 | $3.35kSell |
| Daljit Singh Aurora | Chief Strategy Officer | 2025-02-18 | 8,565 | $1.68 | $14.35kSell |
NMRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NMRA insiders and whales buy or sell their stock.
NMRA Shareholders
What type of owners hold Neumora Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kristina Burow | 30.51% | 49,406,456 | $144.76M | Insider |
| Amgen Inc | 21.84% | 35,368,653 | $103.63M | Insider |
| Arch Venture Partners X LLC | 20.90% | 33,847,838 | $99.17M | Insider |
| Arch Venture Partners XII LLC | 20.90% | 33,847,838 | $99.17M | Insider |
| Paul L. Berns | 4.65% | 7,538,101 | $22.09M | Insider |
| Softbank Group Corp | 4.04% | 6,541,190 | $19.17M | Institution |
| Vanguard Group Inc | 2.94% | 4,762,903 | $13.96M | Institution |
| MIC Capital Management Uk LLP | 2.75% | 4,460,700 | $13.07M | Institution |
| Siren LLC | 2.69% | 4,358,283 | $12.77M | Institution |
| Fmr LLC | 2.16% | 3,502,666 | $10.26M | Institution |
NMRA vs Biotech Stocks
Neumora Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.